Abstract
This prospective study was conducted to assess dialysate cancer antigen 125 (dCA125) levels in pediatric peritoneal dialysis (PD) patients and to investigate whether it exhibits any alterations during or after recovery from peritonitis, and also to analyze the relationships between dCA125 and age, duration of PD treatment, peritonitis incidence, time passed since the last episode of peritonitis, PD prescription parameters, and peritoneal transport parameters. Forty-seven standardized 4-h peritoneal equilibration tests (PET) were performed in 38 children (mean age 11.6±4.7 years) on PD (duration 20.9±14.3 months). Thirty-two of the patients were in stable condition at the time of PET (stable group). Six patients were included in the study only during a peritonitis episode, and two of the stable patients were reevaluated during a peritonitis episode afterwards (peritonitis group). Seven out of a total of eight patients with acute peritonitis were reexamined after recovery (recovery group). CA125 levels were measured in 188 samples at 0-, 1-, 2-, and 4-h dwells. Peritoneal appearance rates (AR) were calculated. Mean dCA125 (4 h) and AR CA125 values were 5.6±5.3 U/ml [median 4.15 U/ml/4 h (range 0.5–25.9)] and 50.1±45.6 U/min/1.73 m2[median 37.91 U/ml/1.73 m2 (range 3.61–223.39)]. AR CA125 levels did not correlate with age, PD duration, peritonitis incidence, time passed since the last peritonitis episode, exchange volume used per m2 per day, or peritoneal transport properties in the stable patients’ group. Although stable patients using hypertonic PD solutions (n=16) had slightly lower AR CA125 levels (p=0.04), multivariate analysis showed no influence of hypertonic dextrose solutions on mesothelial CA125 secretion (p=0.4). During acute peritonitis, CA125 concentrations showed a reversible threefold increase [AR CA125: stable 37.9 vs. peritonitis 101.2 U/ml/1.73 m2 (p=0.001)]. No difference could be found between the stable group and the recovery group. We conclude that changes in the peritoneal mesothelial cell mass cannot be assessed by determining CA125 in a cross-sectional way and that longitudinal determinations could be more valuable in the follow-up of patients.
Similar content being viewed by others
References
Krediet RT (2001) Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis. Perit Dial Int 21:560–7
Pannekeet MM, Zemel D, Koomen GCM, Struijk DG, Krediet RT (1995) Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Perit Dial Int 15:217–25
Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT; Peritoneal Biopsy Study Group (2002) Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470–9
Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT (1997) Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis. Adv Perit Dial 13:17–22
Koomen GCM, Betjes MGH, Zemel D, Krediet RT, Hoek FJ (1994) Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Perit Dial Int 14:132–6
Zeillemaker AM, Verbrugh HA, Hoynck van Papendrecht AAGM, Leguit P (1994) CA125 secretion by peritoneal mesothelial cells. J Clin Pathol 47:263–5
Ho-dac-Pannekeet MM (1998) Peritoneal fluid markers of mesothelial cells and function. Adv Renal Rep Ther 5:205–11
Visser CE, Brouwer-Steenbergen JJE, Betjes MGH, Koomen GCM, Beelen RHJ, Krediet RT (1995) Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant 10:64–9
Bouts AHM, Groothoff JW, van Amstel SP, Zweers MM, Davin JC, Krediet RT (2000) Dialysate CA125 levels in children treated with peritoneal dialysis. Adv Perit Dial 16:328–31
Haas S, Schmitt CP, Arbeiter K, Bonzel KE, Fischbach M, John U, Pieper AK, Schaub TP, Passlick-Deetjen J, Mehls O, Schaefer F (2003) Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis. J Am Soc Nephrol 14:2632–8
Leehey DJ, Gandhi VC, Daugirdas JT (2001) Peritonitis and exit site infection. In: Daugirdas JT, Blake PG, Ing TS (eds) Handbook of dialysis, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 375–8
Warady BA, Alexander SR, Hossli S, Vonesh E, Geary D, Watkins S, Salusky IB, Kohaut EC (1996) Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol 7:2385–91
Kawanishi H, Moriishi M, Harada Y, Sakikubo, Nagai T, Tsuchiya S (2000) Necessity of correcting cancer antigen 125 appearance rates by body surface area. Adv Perit Dial 16:22–5
Twardowski ZJ (1989) Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 7:95–108
Holtta TM, Ronnholm KA, Holmberg C (1998) Influence of age, time, and peritonitis on peritoneal transport kinetics in children. Perit Dial Int 18:590–7
Passadakis P, Panagoutsos S, Thodis E, Tsivara I, Sopassi F, Kartali S, Vargemezis V (1999) Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 15:40–4
Okada T, Nakao T, Matsumoto H (1999) Dialysate CA125 levels in stable peritoneal dialysis patients. Clin Nephrol 51:65–6
Pannekeet MM, Koomen GCM, Struijk DG, Krediet RT (1995) Dialysate CA125 in stable CAPD patients: no relation with transport parameters. Clin Nephrol 44:248–54
Ho-dac-Pannekeet MM, Hiralall JK, Struijk DG, Krediet RT (1997) Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int 51:888-93
Fusshöller A, Grabense B, Plum J (2003) Effluent CA125 concentration in chronic peritoneal dialysis patients: influence of PD duration, peritoneal transport and PD regimen. Kidney Blood Press Res 26:118–22
Jimenez C, Diaz C, Selgas R, Bajo MA, del Paso G, Sanchez-Tomero JA, Gonzalez-Gancedo P (1999) Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcome. Adv Perit Dial 15:36–9
Sanusi AA, Zweers MM, Weening JJ, de Waart DR, Struijk DG, Krediet RT (2001) Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis. Perit Dial Int 21:495–500
Ateş K, Koç R, Negizoğlu G, Ertürk Ş, Keven K, Sen A, Karatan O (2000) The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD patients. Perit Dial Int 20:220–6
Yoshino A, Honda M, Fukuda M, Araki Y, Hataya H, Sakazume S, Tanaka Y, Kawamura K, Murai T, Kamiyama Y (2001) Changes in peritoneal equilibration test values during long-term peritoneal dialysis in peritonitis-free children. Perit Dial Int 21:180–5
Lai KN, Lai KB, Szeto CC, Ho KKL, Poon P, Lam CWK, Leung JCK (1997) Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. Am J Kidney Dis 29:699–705
Acknowledgements
This study was presented as an oral presentation at the IX Congress of the International Society for Peritoneal Dialysis, 26–29 June 2001, Montreal, Canada. We acknowledge Dr. Selami Erarslan and Dr. Hasan Önal for their excellent technical assistance. This study was supported financially by the Research Fund of the University of Istanbul, project number T-797/0703200.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Turhan, P., Sever, L., Caliskan, S. et al. Dialysate CA125 levels in children on continuous peritoneal dialysis. Pediatr Nephrol 20, 1615–1621 (2005). https://doi.org/10.1007/s00467-005-2007-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-005-2007-5